Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Change in Receivables: 2013-2024

Historic Change in Receivables for Surgery Partners (SGRY) over the last 11 years, with FY2024 value amounting to $72.1 million.

  • Surgery Partners' Change in Receivables fell 1518.32% to $16.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year decrease of 8875.97%. This contributed to the annual value of $72.1 million for FY2024, which is 5275.42% up from last year.
  • According to the latest figures from FY2024, Surgery Partners' Change in Receivables is $72.1 million, which was up 5275.42% from $47.2 million recorded in FY2023.
  • Surgery Partners' 5-year Change in Receivables high stood at $72.1 million for FY2024, and its period low was $32.1 million during FY2021.
  • Over the past 5 years, Surgery Partners' median Change in Receivables value was $46.6 million (recorded in 2020), while the average stood at $46.7 million.
  • Its Change in Receivables has fluctuated over the past 5 years, first surged by 9829.79% in 2020, then tumbled by 3111.59% in 2021.
  • Over the past 5 years, Surgery Partners' Change in Receivables (Annual) stood at $46.6 million in 2020, then tumbled by 31.12% to $32.1 million in 2021, then rose by 9.97% to $35.3 million in 2022, then skyrocketed by 33.71% to $47.2 million in 2023, then soared by 52.75% to $72.1 million in 2024.
  • Its Change in Receivables was $72.1 million in FY2024, compared to $47.2 million in FY2023 and $35.3 million in FY2022.